The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor
AmnioChor is a biotech startup engaged in perinatal stem cell technologies, founded with a long term vision and operating on a near term mandate. The vision is the ability to satisfy the therapeutic needs of Mesenchymal and Epithelial stem cells as the critical high volume foundation of new cures. The immediate mandate is to create the bank to serve that need through the cryopreservation of the living amniotic membrane of the placental sac. - August 06, 2015
Press Releases 1 - 1 of 1